Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Methamphetamine Dependence in MSM
NCT00318409Phase 2Completed
- Sponsor
- San Francisco Department of Public Health
- Start
- Sep 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupropion in methamphetamine use disorder (MUD), sponsored by San Francisco Department of Public Health. Started Sep 2006; status: completed.
02
Drugs
bupropion
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00318409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318409.